Total Payments
$15,738
2024 Payments
$694.86
Companies
21
Transactions
65
Medicare Patients
6,193
Medicare Billing
$901,436
Payment Breakdown by Category
Other$12,500 (79.4%)
Food & Beverage$2,483 (15.8%)
Travel$690.39 (4.4%)
Education$64.45 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $12,500 | 1 | 79.4% |
| Food and Beverage | $2,483 | 57 | 15.8% |
| Travel and Lodging | $690.39 | 2 | 4.4% |
| Education | $64.45 | 1 | 0.4% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$15,738
61 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $14,361 | 18 | $0 (2024) |
| ABBVIE INC. | $229.48 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $169.02 | 8 | $0 (2024) |
| ERBE USA INC | $134.91 | 1 | $0 (2024) |
| Medtronic, Inc. | $133.13 | 1 | $0 (2024) |
| Apollo Endosurgery US Inc | $118.96 | 1 | $0 (2023) |
| Olympus America Inc. | $101.64 | 4 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $81.88 | 5 | $0 (2023) |
| CONMED Corporation | $72.84 | 1 | $0 (2021) |
| Celgene Corporation | $72.54 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $694.86 | 14 | ERBE USA INC ($134.91) |
| 2023 | $243.60 | 9 | Apollo Endosurgery US Inc ($118.96) |
| 2022 | $117.87 | 7 | ABBVIE INC. ($52.94) |
| 2021 | $392.68 | 14 | BOSTON SCIENTIFIC CORPORATION ($107.71) |
| 2020 | $191.77 | 2 | Boston Scientific Corporation ($125.07) |
| 2019 | $1,216 | 10 | Boston Scientific Corporation ($1,177) |
| 2018 | $303.74 | 6 | BOSTON SCIENTIFIC CORPORATION ($291.95) |
| 2017 | $12,577 | 3 | BOSTON SCIENTIFIC CORPORATION ($12,552) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/09/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: GI | ||||||
| 05/09/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $107.28 | General |
| Category: EXALT Model D_ENDO | ||||||
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $36.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/27/2024 | ERBE USA INC | VIO3 APC3 EJ2 (Device) | Food and Beverage | Cash or cash equivalent | $134.91 | General |
| Category: Gastroenterology | ||||||
| 03/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 02/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $88.13 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $133.13 | General |
| Category: Gastrointestinal AI | ||||||
| 01/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $39.57 | General |
| Category: Neuroscience | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 09/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Gastroenterology | ||||||
| 08/24/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| Category: Neuroscience | ||||||
| 07/27/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2023 | Apollo Endosurgery US Inc | OverStitch Endoscopic Suturing System (Device) | Food and Beverage | In-kind items and services | $118.96 | General |
| Category: ENDOSCOPIC TISSUE APPROXIMATION DEVICE | ||||||
| 03/10/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/20/2023 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 2023 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 11/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/11/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 1,295 | 8,396 | $2.0M | $268,308 |
| 2022 | 35 | 1,309 | 4,026 | $1.8M | $216,396 |
| 2021 | 37 | 1,693 | 2,372 | $1.0M | $197,967 |
| 2020 | 39 | 1,896 | 2,302 | $1.1M | $218,765 |
Total Patients
6,193
Total Services
17,096
Medicare Billing
$901,436
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 16 | 4,800 | $326,400 | $83,007 | 25.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 15 | 1,218 | $360,528 | $32,195 | 8.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 69 | 725 | $110,200 | $24,057 | 21.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 70 | 408 | $40,800 | $17,788 | 43.6% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 88 | $78,564 | $12,927 | 16.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 58 | 58 | $103,095 | $9,847 | 9.6% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 57 | 58 | $58,537 | $9,576 | 16.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 100 | $25,987 | $9,304 | 35.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 64 | $25,329 | $8,039 | 31.7% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 21 | 23 | $41,429 | $7,519 | 18.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 156 | 159 | $222,490 | $7,266 | 3.3% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 25 | 25 | $33,213 | $5,496 | 16.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 54 | 55 | $91,748 | $5,495 | 6.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 70 | 86 | $12,010 | $5,049 | 42.0% |
| 43270 | Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 20 | $57,160 | $3,024 | 5.3% |
| 43254 | Removal of tissue lining of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $14,959 | $2,743 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,964 | $2,736 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 34 | $7,378 | $2,684 | 36.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 22 | 22 | $34,270 | $2,142 | 6.3% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 12 | 14 | $132,356 | $2,132 | 1.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 20 | 24 | $84,282 | $1,969 | 2.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $4,736 | $1,828 | 38.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 24 | 26 | $14,638 | $1,798 | 12.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 52 | $9,360 | $1,730 | 18.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 48 | $7,200 | $1,668 | 23.2% |
About Dr. Ralph Vance, MD
Dr. Ralph Vance, MD is a Gastroenterology healthcare provider based in Flowood, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1487974192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Vance, MD has received a total of $15,738 in payments from pharmaceutical and medical device companies, with $694.86 received in 2024. These payments were reported across 65 transactions from 21 companies. The most common payment nature is "Grant" ($12,500).
As a Medicare-enrolled provider, Vance has provided services to 6,193 Medicare beneficiaries, totaling 17,096 services with total Medicare billing of $901,436. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Flowood, MS
- Active Since 06/03/2010
- Last Updated 01/24/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487974192
Products in Payments
- GENERAL - BILIARY DEVICES (Device) $12,500
- RESOLUTION CLIP (Device) $484.28
- ORISE (Device) $394.20
- SPYGLASS (Device) $216.81
- GENERAL THERAPIES (Device) $206.11
- AXIOS (Device) $144.12
- ENTYVIO (Biological) $141.33
- VIO3 APC3 EJ2 (Device) $134.91
- GI GENIUS (Device) $133.13
- OverStitch Endoscopic Suturing System (Device) $118.96
- SKYRIZI (Biological) $117.73
- GENERAL BILIARY DEVICES (Device) $111.64
- EXALT Model D (Device) $107.28
- EXALT (Device) $95.83
- GENERAL METAL STENTS GI (Device) $90.97
- XIFAXAN (Drug) $81.88
- Olympus Biliary Devices (Device) $78.49
- CONMED BILIARY (Device) $72.84
- ZEPOSIA (Drug) $72.54
- GORE VIABIL Biliary Endoprosthesis (Device) $64.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Flowood
Reed Hogan, Md, MD
Gastroenterology — Payments: $206,012
Gastroenterology $206,012
Vonda Reeves, Md, MD
Gastroenterology — Payments: $32,497
Gastroenterology $32,497
Dr. Ernest Weeks, M.d, M.D
Gastroenterology — Payments: $31,833
Gastroenterology $31,833
Dr. Jane-Claire Williams, M.d, M.D
Gastroenterology — Payments: $29,263
Gastroenterology $29,263
Ronald Kotfila, Md, MD
Gastroenterology — Payments: $10,599
Gastroenterology $10,599
Dr. Reed Hogan, M.d, M.D
Gastroenterology — Payments: $9,406
Gastroenterology $9,406